ITMCTR2100004850招募中1 期
Efficacy and Safety of Jiannao Tongluo Granules in Cognitive Impairment After Cerebral Infarction: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Hubei Provincial Hospital of Integrated Chinese and Western Medicine0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 40 至 75（—）
- 性别
- All
入选标准
- •1. It meets the diagnostic criteria of cerebral infarction and is confirmed by head CT or MRI;
- •2. Comply with the standard of TCM stroke-wind, phlegm and blood stasis syndrome;
- •3. In the recovery period (the course of illness is 2 weeks to 6 months)
- •4. Aged 40 to 75 years;
- •5. For the first time, the vital signs are stable, the consciousness is clear, and they can cooperate with the examination and treatment;
- •6. The subject has an education level of elementary school or above, and is capable of completing cognitive function assessment;
- •7. Montreal Cognitive Assessment Scale (MoCA) score <26 points;
- •8. Volunteer to participate in this study and sign an informed consent.
排除标准
- •1. Patients with severe cardiovascular, cerebrovascular, liver, kidney, malignant tumors, hematological diseases, and mental illnesses;
- •2. Transient organic psychosis and other mental illnesses (such as depression, schizophrenia), or other mental disorders that meet the DSM-IV-R standards;
- •3. Those who have other diseases that affect the function of limbs, and those who have dysfunction of limbs caused by claudication, osteoarthritis, rheumatoid arthritis, gouty arthritis, etc. before treatment may affect nerve or functional examination;
- •4. Those who are allergic to test drug ingredients, or have a history of alcohol or drug abuse;
- •5. Women who are pregnant or breastfeeding, or have a pregnancy plan within the past 6 months, or who cannot use effective contraceptive measures (sterilization, long-term use of contraceptives/drugs, condoms, or removal of the vas deferens from their partners, etc.);
- •6. Participating in other clinical trials or participating in other drug clinical trials within 3 months;
- •7. Patients judged by the investigator to be unsuitable to participate in this trial.
研究者
相似试验
招募中
1 期
Efficacy and Safety of Jiannao Tongluo Granules in Motor Dysfunction After Cerebral Infarction: a Randomized, Double-Blind, Placebo-Controlled Clinical TrialstrokeITMCTR2100004804Hubei Provincial Hospital of Integrated Chinese and Western Medicine
尚未招募
4 期
The efficacy and safety of Jingfang Granules in treating air-conditioning diseasesThe Disease of Air ConditioningITMCTR2000003664Zhangjiagang Hospital of Traditional Chinese Medicine
尚未招募
不适用
The efficacy and safety of Ganduqing granule for treating common cold with qi deficiency leading to lingering of evil syndrome: a randomized, double-blind, placebo, parallel-group, multicenter- controlled trialCommon ColdITMCTR1900002681Hospital of of Chengdu University of Traditional Chinese Medicine
已完成
4 期
Efficacy and safety of Niaoqingshu granules in the treatment of chronic pelvic pain syndrome(syndrome of dampness-heat diffusing downward)chronic pelvic pain syndrome(syndrome of dampness-heat diffusing downward)ITMCTR2200005579The First Affiliated Hospital of Tianjin University of Chinese Medicine
尚未招募
不适用
Effectiveness and safety of Yifei Sanjie Granule in people with Pulmonary Mixed Nodules: A prospective controlled studyPulmonary Mixed NodulesITMCTR2200006146The Third Affiliated Hospital of Henan University of Chinese Medicine